The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Carrier Screening-Global Market Insights and Sales Trends 2024
Synopsis
Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive diseases.
The global Carrier Screening market size is expected to reach US$ 1934.9 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Carrier Screening in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Carrier Screening market. Molecular Screening Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biochemical Screening Test segment is estimated at % CAGR for the next seven-year period.
Asia-Pacific is expected to record the highest CAGR of 10% during the forecast period. Increasing investments in R&D activities, production, and rising indigenous production are propelling the market in Asia-Pacific. However, the North American region holds the largest share in the carrier screening market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Carrier Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Carrier Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Carrier Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Carrier Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Carrier Screening covered in this report include Abbott Laboratories, Roche, Thermo Fisher Scientific, 23andMe, Danaher, Illumina, Luminex, LabCorp and Myriad Genetics, etc.
The global Carrier Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Roche
Thermo Fisher Scientific
23andMe
Danaher
Illumina
Luminex
LabCorp
Myriad Genetics
Autogenomics
Global Carrier Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Carrier Screening market, Segment by Type:
Molecular Screening Test
Biochemical Screening Test
Global Carrier Screening market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Carrier Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive diseases.
The global Carrier Screening market size is expected to reach US$ 1934.9 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Carrier Screening in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Carrier Screening market. Molecular Screening Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biochemical Screening Test segment is estimated at % CAGR for the next seven-year period.
Asia-Pacific is expected to record the highest CAGR of 10% during the forecast period. Increasing investments in R&D activities, production, and rising indigenous production are propelling the market in Asia-Pacific. However, the North American region holds the largest share in the carrier screening market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Carrier Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Carrier Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Carrier Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Carrier Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Carrier Screening covered in this report include Abbott Laboratories, Roche, Thermo Fisher Scientific, 23andMe, Danaher, Illumina, Luminex, LabCorp and Myriad Genetics, etc.
The global Carrier Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Roche
Thermo Fisher Scientific
23andMe
Danaher
Illumina
Luminex
LabCorp
Myriad Genetics
Autogenomics
Global Carrier Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Carrier Screening market, Segment by Type:
Molecular Screening Test
Biochemical Screening Test
Global Carrier Screening market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Carrier Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Carrier Screening
1.1 Carrier Screening Market Overview
1.1.1 Carrier Screening Product Scope
1.1.2 Carrier Screening Market Status and Outlook
1.2 Global Carrier Screening Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Carrier Screening Market Size by Region (2018-2029)
1.4 Global Carrier Screening Historic Market Size by Region (2018-2023)
1.5 Global Carrier Screening Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Carrier Screening Market Size (2018-2029)
1.6.1 North America Carrier Screening Market Size (2018-2029)
1.6.2 Europe Carrier Screening Market Size (2018-2029)
1.6.3 Asia-Pacific Carrier Screening Market Size (2018-2029)
1.6.4 Latin America Carrier Screening Market Size (2018-2029)
1.6.5 Middle East & Africa Carrier Screening Market Size (2018-2029)
2 Carrier Screening Market by Type
2.1 Introduction
2.1.1 Molecular Screening Test
2.1.2 Biochemical Screening Test
2.2 Global Carrier Screening Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Carrier Screening Historic Market Size by Type (2018-2023)
2.2.2 Global Carrier Screening Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Carrier Screening Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Carrier Screening Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Carrier Screening Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Carrier Screening Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Carrier Screening Revenue Breakdown by Type (2018-2029)
3 Carrier Screening Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Carrier Screening Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Carrier Screening Historic Market Size by Application (2018-2023)
3.2.2 Global Carrier Screening Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Carrier Screening Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Carrier Screening Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Carrier Screening Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Carrier Screening Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Carrier Screening Revenue Breakdown by Application (2018-2029)
4 Carrier Screening Competition Analysis by Players
4.1 Global Carrier Screening Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Carrier Screening as of 2022)
4.3 Date of Key Players Enter into Carrier Screening Market
4.4 Global Top Players Carrier Screening Headquarters and Area Served
4.5 Key Players Carrier Screening Product Solution and Service
4.6 Competitive Status
4.6.1 Carrier Screening Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Carrier Screening Products, Services and Solutions
5.1.4 Abbott Laboratories Carrier Screening Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Carrier Screening Products, Services and Solutions
5.2.4 Roche Carrier Screening Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Carrier Screening Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Carrier Screening Revenue (US$ Million) & (2018-2023)
5.3.5 23andMe Recent Developments
5.4 23andMe
5.4.1 23andMe Profile
5.4.2 23andMe Main Business
5.4.3 23andMe Carrier Screening Products, Services and Solutions
5.4.4 23andMe Carrier Screening Revenue (US$ Million) & (2018-2023)
5.4.5 23andMe Recent Developments
5.5 Danaher
5.5.1 Danaher Profile
5.5.2 Danaher Main Business
5.5.3 Danaher Carrier Screening Products, Services and Solutions
5.5.4 Danaher Carrier Screening Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Recent Developments
5.6 Illumina
5.6.1 Illumina Profile
5.6.2 Illumina Main Business
5.6.3 Illumina Carrier Screening Products, Services and Solutions
5.6.4 Illumina Carrier Screening Revenue (US$ Million) & (2018-2023)
5.6.5 Illumina Recent Developments
5.7 Luminex
5.7.1 Luminex Profile
5.7.2 Luminex Main Business
5.7.3 Luminex Carrier Screening Products, Services and Solutions
5.7.4 Luminex Carrier Screening Revenue (US$ Million) & (2018-2023)
5.7.5 Luminex Recent Developments
5.8 LabCorp
5.8.1 LabCorp Profile
5.8.2 LabCorp Main Business
5.8.3 LabCorp Carrier Screening Products, Services and Solutions
5.8.4 LabCorp Carrier Screening Revenue (US$ Million) & (2018-2023)
5.8.5 LabCorp Recent Developments
5.9 Myriad Genetics
5.9.1 Myriad Genetics Profile
5.9.2 Myriad Genetics Main Business
5.9.3 Myriad Genetics Carrier Screening Products, Services and Solutions
5.9.4 Myriad Genetics Carrier Screening Revenue (US$ Million) & (2018-2023)
5.9.5 Myriad Genetics Recent Developments
5.10 Autogenomics
5.10.1 Autogenomics Profile
5.10.2 Autogenomics Main Business
5.10.3 Autogenomics Carrier Screening Products, Services and Solutions
5.10.4 Autogenomics Carrier Screening Revenue (US$ Million) & (2018-2023)
5.10.5 Autogenomics Recent Developments
6 North America
6.1 North America Carrier Screening Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Carrier Screening Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Carrier Screening Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Carrier Screening Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Carrier Screening Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Carrier Screening Market Dynamics
11.1 Carrier Screening Industry Trends
11.2 Carrier Screening Market Drivers
11.3 Carrier Screening Market Challenges
11.4 Carrier Screening Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
